NCT02230800View on ClinicalTrials.gov

PPALM-Palm Oil and Pentoxifylline Against Late Morbidity

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 25, 2014

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Long-term Adverse Effects of Radiotherapy for Pelvic Cancer
Interventions
DRUG

Tocovid SupraBio plus pentoxifylline

DRUG

Matching placebos

Trial Locations (1)

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

All Listed Sponsors
collaborator

Malaysia Palm Oil Board

OTHER_GOV

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT02230800 - PPALM-Palm Oil and Pentoxifylline Against Late Morbidity | Biotech Hunter | Biotech Hunter